2018
DOI: 10.1136/jnnp-2017-317783
|View full text |Cite
|
Sign up to set email alerts
|

Systematic review and network meta-analysis of resective surgery for mesial temporal lobe epilepsy

Abstract: Direct evidence, indirect evidence and NMA did not identify a difference in seizure-free outcome of ATL versus SAH.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
28
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 51 publications
(32 citation statements)
references
References 66 publications
3
28
1
Order By: Relevance
“…The probability of being seizure-free at 1-year following surgery [0.652 (95% CI: 0.567–0.728)] was based on the study by Jain et al . [20]. We used the study by Choi et al .…”
Section: Methodsmentioning
confidence: 99%
“…The probability of being seizure-free at 1-year following surgery [0.652 (95% CI: 0.567–0.728)] was based on the study by Jain et al . [20]. We used the study by Choi et al .…”
Section: Methodsmentioning
confidence: 99%
“…More recent adaptations include (i) the modified Engel classification, which assesses postoperative seizure outcomes annually and in seizures days instead of an absolute seizure number to allow better comparison between individual patients, different centers and AEDs [12] and (ii) the ILAE classification, where the terminology was re-defined and seizures were classified based on their onset, specification of motor symptoms and non-motor symptoms [13]. Seizure outcomes for ATL and SAH were reported equivalent, regardless of surgery or approach [14]: A 71% seizure-freedom rate after >10 year follow-up was shown with the transsylvian approach [15]; similar rates were described for the transcortical and subtemporal approaches [16][17][18]. This notion has however been recently challenged by several meta-analyses favoring higher seizure freedom with ATL, although rates of seizure freedom were only subtlety different [19,20].…”
Section: Traditional Surgical Treatment Options In Pharmacoresistant mentioning
confidence: 99%
“…Standardized anterior temporal lobectomy in patients with temporal lobe epilepsy involves removing 4-6 cm of the anterior temporal lobe, including the amygdala and hippocampus. Selective amygdalohippocampectomy preserves the temporal neocortex and underlying white matter and offers the theoretical advantage of lower cognitive decline following surgery 48) . Both approaches showed 50-70% similar seizure-free rate, 48-100% post-operative risk of permanent visual field defects, and 30-60% risk of verbal and visual memory decline 49,50) .…”
Section: Resective Surgerymentioning
confidence: 99%